{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:10:04Z","timestamp":1792408204004,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011702","name":"Childhood Eye Cancer Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.modpat.2025.100774","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:14:00Z","timestamp":1744370040000},"page":"100774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC Rearrangement"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-5174","authenticated-orcid":false,"given":"Beata","family":"Grygalewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz M.","family":"Szafron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Szafron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Woroniecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pienkowska-Grela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Rygier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Malawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wojtkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Bystydzienski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Blachnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2025.100774_bib1","series-title":"WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours","year":"2024"},{"issue":"12","key":"10.1016\/j.modpat.2025.100774_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2025.100774_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","article-title":"A diagnostic approach to the identification of Burkitt-like lymphoma with 11q aberration in aggressive B-cell lymphomas","volume":"45","author":"Horn","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100774_bib4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2025.100774_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3324\/haematol.2015.124305","article-title":"Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain\/loss pattern","volume":"100","author":"Ferreiro","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.modpat.2025.100774_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like lymphoma with 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100774_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1182\/asheducation-2018.1.69","article-title":"Genomics of aggressive B-cell lymphoma","volume":"2018","author":"Rosenthal","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.modpat.2025.100774_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood-2018-08-864728","article-title":"Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient","volume":"133","author":"Moshref Razavi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2025.100774_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13000-019-0876-3","article-title":"A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma","volume":"14","author":"Liu","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2025.100774_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cancergen.2019.09.001","article-title":"Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis","volume":"239","author":"Strobel","year":"2019","journal-title":"Cancer Genet"},{"issue":"9","key":"10.1016\/j.modpat.2025.100774_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.modpat.2025.100774_bib13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/ccr3.2361","article-title":"Burkitt-like lymphoma with 11q aberration","volume":"7","author":"Collins","year":"2019","journal-title":"Clin Case Rep"},{"issue":"22","key":"10.1016\/j.modpat.2025.100774_bib14","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1182\/bloodadvances.2021004635","article-title":"Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma","volume":"5","author":"Gebauer","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3343\/alm.2021.41.6.593","article-title":"A case of Burkitt-like lymphoma with 11q aberration with HIV infection in East Asia and literature review","volume":"41","author":"Kim","year":"2021","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.modpat.2025.100774_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2023.03.013","article-title":"High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic and molecular characterization of 4 cases","volume":"136","author":"Shestakova","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2025.100774_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2020.05.001","article-title":"Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-gain\/loss and MYC amplification","volume":"245","author":"Grygalewicz","year":"2020","journal-title":"Cancer Genet"},{"issue":"9","key":"10.1016\/j.modpat.2025.100774_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2025.100774_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergen.2015.12.005","article-title":"The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma","volume":"209","author":"Havelange","year":"2016","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.modpat.2025.100774_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263980","article-title":"Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature","volume":"17","author":"Woroniecka","year":"2022","journal-title":"PLOS One"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.modpat.2025.100774_bib22","article-title":"Burkitt-like lymphoma with 11q aberration: a case report and review of a rare entity","volume":"2020","author":"Asadbeigi","year":"2020","journal-title":"Case Rep Hematol"},{"issue":"16","key":"10.1016\/j.modpat.2025.100774_bib23","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1182\/blood.2021012824","article-title":"Primary splenic Burkitt-like lymphoma with 11q aberration","volume":"138","author":"Okwan-Duodu","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2025.100774_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/pjp.2018.75332","article-title":"Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organization\u2019s 2017 classification","volume":"69","author":"Szumera-Cie\u0107kiewicz","year":"2018","journal-title":"Pol J Pathol"},{"issue":"20","key":"10.1016\/j.modpat.2025.100774_bib25","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2025.100774_bib26","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.modpat.2025.100774_bib27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2025.100774_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.13849","article-title":"The presence of genomic imbalances is associated with poor outcome in patients with Burkitt lymphoma treated with dose-intensive chemotherapy including rituximab","volume":"172","author":"Forero-Castro","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100774_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41375-021-01444-6","article-title":"Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma","volume":"36","author":"Newman","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2025.100774_bib31","series-title":"Investigating Chemoresistance in Relapsed\/Refractory B Cell non-Hodgkin Lymphoma. Master's Thesis","author":"Neuman","year":"2020"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2013.08.016","article-title":"Structure and subunit topology of the INO80 chromatin remodeler and its nucleosome complex","volume":"154","author":"Tosi","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.modpat.2025.100774_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2008.10.010","article-title":"The INO80 chromatin remodeling complex in transcription, replication and repair","volume":"34","author":"Conaway","year":"2009","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2004.11.033","article-title":"Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand repair","volume":"119","author":"van Attikum","year":"2004","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.modpat.2025.100774_bib35","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2013-01-475772","article-title":"Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma","volume":"122","author":"Bonetti","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2025.100774_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.19018","article-title":"ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells","volume":"203","author":"Chung","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100774_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.21225","article-title":"c-MYC Asn11Ser is associated with increased risk for familial breast cancer","volume":"117","author":"Wirtenberger","year":"2005","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.modpat.2025.100774_bib38","first-page":"3383","article-title":"Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas","volume":"54","author":"Clark","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2025.100774_bib39","article-title":"Single nucleotide polymorphisms of the c-MYC gene\u2019s relationship with formation of Burkitt\u2019s lymphoma using bioinformatics analysis","author":"Sati","year":"2018","journal-title":"bioRxiv"},{"issue":"14","key":"10.1016\/j.modpat.2025.100774_bib40","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-15-2296","article-title":"Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B-cell lymphoma","volume":"22","author":"Xu-Monette","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2025.100774_bib41","first-page":"2155","article-title":"Bioinsilico analysis of c-MYC gene association with Burkitt\u2019s Lymphoma","volume":"9","author":"Ahmedon","year":"2020","journal-title":"J Nanomed Biother Discov"},{"issue":"16","key":"10.1016\/j.modpat.2025.100774_bib42","first-page":"2196","article-title":"The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC","volume":"137","author":"Collinge","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2025.100774_bib43","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3324\/haematol.2021.280543","article-title":"Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma","volume":"107","author":"Kim","year":"2022","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.modpat.2025.100774_bib44","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/cancers13133352","article-title":"Molecular update and evolving classification of large B-cell lymphoma","volume":"13","author":"Onaindia","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib45","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3324\/haematol.2016.156885","article-title":"Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-M\u00fcnster protocols","volume":"102","author":"Rohde","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.modpat.2025.100774_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.61","article-title":"MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma","volume":"7","author":"Xiong","year":"2017","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.modpat.2025.100774_bib47","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/MCB.26.6.2373-2386.2006","article-title":"Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis","volume":"26","author":"O\u2019Donnell","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100774_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:00:21Z","timestamp":1762315221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0893395225000705"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100774","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC Rearrangement","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100774"}}